Quick Answer
Beam Therapeutics Inc. reported Shares Outstanding of 101.75 million shares for fiscal year 2025.
Beam Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 101.75M | +21.7% |
| 2024 | 83.63M | +2.5% |
| 2023 | 81.63M | +14.5% |
| 2022 | 71.28M | +4.2% |
| 2021 | 68.39M | +19.4% |
| 2020 | 57.25M | +681.5% |
| 2019 | 7.33M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 101.36M | +22.8% | +0.6% |
| June 30, 2025 | 100.76M | +22.3% | +0.2% |
| March 31, 2025 | 100.56M | +22.2% | +20.2% |
| December 31, 2024 | 83.63M | +2.5% | +1.3% |
| September 30, 2024 | 82.56M | +4.0% | +0.2% |
| June 30, 2024 | 82.39M | +5.7% | +0.1% |
| March 31, 2024 | 82.28M | +10.5% | +0.8% |
| December 31, 2023 | 81.63M | +14.5% | +2.8% |
- Beam Therapeutics Inc. showed an increase of +21.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Beam Therapeutics Inc.’s shares outstanding has grown by 1288.8% (from 7.33 million shares to 101.75 million shares).
- The most recent figure is from Beam Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: